Creatinine to Body Weight Ratio Is Associated with Incident Diabetes: Population-Based Cohort Study.

creatinine diabetes epidemiology muscle mass skeletal muscle mass

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
15 Jan 2020
Historique:
received: 13 12 2019
revised: 29 12 2019
accepted: 08 01 2020
entrez: 19 1 2020
pubmed: 19 1 2020
medline: 19 1 2020
Statut: epublish

Résumé

We investigated the association between creatinine to body weight (Cre/BW) ratio and incident diabetes. In this cohort study, 9659 men and 7417 women were follow up mean (SD) 5.6 (3.5) years and 5.4 (3.4) years, respectively. For men, tertile 1 (T1; n = 3176), Cre/BW < 0.01275; tertile 2 (T2; n = 3258), 0.01275 ≤ Cre/BW < 0.0148; and tertile 3 (T3; n = 3225), Cre/BW ≥ 0.0148; and for women, T1 (n = 2,437), Cre/BMI < 0.0118; T2 (n = 2,516), 0.0118 ≤ Cre/BMI < 0.014; and T3 (n = 2477), Cre/BMI ≥ 0.014. Among them, 362 men and 102 women developed diabetes. The hazard ratios (HRs) of incident diabetes in the T2 group was 0.56 (95% CI 0.44-0.71,

Identifiants

pubmed: 31952309
pii: jcm9010227
doi: 10.3390/jcm9010227
pmc: PMC7020036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

Potential conflicts of interest are as follows: Y.H. has received grant support from Asahi Kasei Pharma. M.F. has received grants, honoraria, and research supports from AstraZeneca plc., Nippon Boehringer Ingelheim Co., Ltd., Sanofi K.K., Daiichi Sankyo Co., Kyowa Hakko Kirin Company Ltd., Kissei Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Kowa Company, Ltd., Novo Nordisk Pharma Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Astellas Pharma Inc., MSD K.K., Ltd., Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Takeda Pharmaceutical Co., Ltd. These sponsors were not concerned with this study. The authors and their immediate families have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The authors received no current funding for this study and this does not alter their adherence to all the journal policies on sharing data and materials. The other authors have nothing to disclose.

Références

Diabetes Care. 2006 Sep;29(9):2102-7
pubmed: 16936160
J Diabetes Investig. 2018 Jan;9(1):3-4
pubmed: 28941204
J Clin Med. 2019 Dec 09;8(12):
pubmed: 31835362
Muscle Nerve. 2009 Sep;40(3):438-42
pubmed: 19623638
Diabetes Metab. 2017 Oct;43(5):460-464
pubmed: 28526322
Int J Obes (Lond). 2019 Jan;43(1):139-148
pubmed: 29717276
Liver Int. 2016 May;36(5):713-20
pubmed: 26444696
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Clin Chem. 2007 Jan;53(1):71-7
pubmed: 17110470
J Hepatol. 2017 Jan;66(1):123-131
pubmed: 27599824
PLoS One. 2013 Sep 06;8(9):e74699
pubmed: 24040326
Hepatol Res. 2020 Jan;50(1):57-66
pubmed: 31692179
J Physiol Anthropol. 2017 Feb 13;36(1):15
pubmed: 28193296
Hepatology. 2014 May;59(5):1772-8
pubmed: 23996808
Diabetes Care. 2009 Mar;32(3):424-6
pubmed: 19074997
J Gastroenterol. 2019 Feb;54(2):160-170
pubmed: 29948305
Ann Intern Med. 2005 Nov 15;143(10):722-8
pubmed: 16287793
J Clin Endocrinol Metab. 2011 Sep;96(9):2898-903
pubmed: 21778224
Diabetes Care. 2012 Jan;35 Suppl 1:S64-71
pubmed: 22187472
Endocr J. 2016 Oct 29;63(10):877-884
pubmed: 27397679
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
Vet Rec. 2018 Feb 26;:
pubmed: 29483150
J Hepatol. 2015 Aug;63(2):486-93
pubmed: 25772036
J Endocr Soc. 2018 Feb 19;2(3):279-289
pubmed: 29600294
Diabetes Metab. 2017 Apr;43(2):184-186
pubmed: 27667529
J Nutr Health Aging. 2016 Mar;20(3):248-55
pubmed: 26892573
Diabetes Metab Syndr Obes. 2019 Apr 15;12:495-503
pubmed: 31114278
Diabetes Care. 2010 Jul;33(7):1652-4
pubmed: 20460442
Aliment Pharmacol Ther. 2017 Feb;45(4):510-518
pubmed: 28028821
Diabetes Res Clin Pract. 2011 Mar;91(3):342-7
pubmed: 21208679
Diabetologia. 2017 May;60(5):865-872
pubmed: 28102434
Nutr Metab Cardiovasc Dis. 2018 Sep;28(9):922-928
pubmed: 30057013
Neurology. 1983 Feb;33(2):158-65
pubmed: 6681656
BMC Endocr Disord. 2010 Apr 18;10:6
pubmed: 20398422
J Diabetes Investig. 2011 Apr 7;2(2):140-7
pubmed: 24843473
Clin J Am Soc Nephrol. 2008 Mar;3(2):348-54
pubmed: 18235143
Diabetes Metab Res Rev. 2018 Sep;34(6):e3011
pubmed: 29633473
J Diabetes Investig. 2019 Sep;10(5):1209-1214
pubmed: 30756513
Diabetes. 2003 Jul;52(7):1799-805
pubmed: 12829649
Clin Nutr. 2019 Feb;38(1):422-428
pubmed: 29287676
Diabetes Metab J. 2013 Dec;37(6):458-64
pubmed: 24404517
J Clin Biochem Nutr. 2017 Sep;61(2):118-122
pubmed: 28955128
Heliyon. 2017 Jul 04;3(7):e00347
pubmed: 28721400
Diabetes. 2007 Apr;56(4):1010-3
pubmed: 17287468
Sci Rep. 2017 Jul 26;7(1):6491
pubmed: 28747657
Endocrinol Metab (Seoul). 2013 Sep;28(3):207-13
pubmed: 24396680

Auteurs

Yoshitaka Hashimoto (Y)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.

Takuro Okamura (T)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.

Masahide Hamaguchi (M)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.

Akihiro Obora (A)

Department of Gastroenterology, Asahi University Hospital, Gifu 501-0223, Japan.

Takao Kojima (T)

Department of Gastroenterology, Asahi University Hospital, Gifu 501-0223, Japan.

Michiaki Fukui (M)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.

Classifications MeSH